世界の注射可能ドラッグデリバリー製剤市場インサイト及び予測(~2026年)

【英語タイトル】Global Injectable Drug Delivery Formulation Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV01692)・商品コード:QYR20NV01692
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:112
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは注射可能ドラッグデリバリー製剤の世界市場について調査・分析した資料です。種類別(従来ドラッグデリバリー製剤、新ドラッグデリバリー製剤、長時間作用型製剤)の市場規模、用途別(自己免疫疾患、ホルモン障害、腫瘍学、希少疾患、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別注射可能ドラッグデリバリー製剤の競争状況、市場シェア
・世界の注射可能ドラッグデリバリー製剤市場:種類別市場規模 2015年-2020年(従来ドラッグデリバリー製剤、新ドラッグデリバリー製剤、長時間作用型製剤)
・世界の注射可能ドラッグデリバリー製剤市場:種類別市場規模予測 2021年-2026年(従来ドラッグデリバリー製剤、新ドラッグデリバリー製剤、長時間作用型製剤)
・世界の注射可能ドラッグデリバリー製剤市場:用途別市場規模 2015年-2020年(自己免疫疾患、ホルモン障害、腫瘍学、希少疾患、その他)
・世界の注射可能ドラッグデリバリー製剤市場:用途別市場規模予測 2021年-2026年(自己免疫疾患、ホルモン障害、腫瘍学、希少疾患、その他)
・北米の注射可能ドラッグデリバリー製剤市場分析:米国、カナダ
・ヨーロッパの注射可能ドラッグデリバリー製剤市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの注射可能ドラッグデリバリー製剤市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の注射可能ドラッグデリバリー製剤市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの注射可能ドラッグデリバリー製剤市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Becton, Dickinson and Company (US)、Baxter International Inc. (US)、Gerresheimer AG (Germany)、Pfizer, Inc. (US)、Schott AG (Germany)、Sandoz (Germany)、Teva Pharmaceutical Industries Ltd. (Israel)、Eli Lilly and Company (US)
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Injectable Drug Delivery Formulation Market
The global Injectable Drug Delivery Formulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Injectable Drug Delivery Formulation Scope and Market Size
Injectable Drug Delivery Formulation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Drug Delivery Formulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Injectable Drug Delivery Formulation market is segmented into
Conventional Drug Delivery Formulations
Novel Drug Delivery Formulations
Long-acting Formulations

Segment by Application, the Injectable Drug Delivery Formulation market is segmented into
Autoimmune Diseases
Hormonal Disorders
Oncology
Orphan Diseases
Others

Regional and Country-level Analysis
The Injectable Drug Delivery Formulation market is analysed and market size information is provided by regions (countries).
The key regions covered in the Injectable Drug Delivery Formulation market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Injectable Drug Delivery Formulation Market Share Analysis
Injectable Drug Delivery Formulation market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Injectable Drug Delivery Formulation business, the date to enter into the Injectable Drug Delivery Formulation market, Injectable Drug Delivery Formulation product introduction, recent developments, etc.

The major vendors covered:
Becton, Dickinson and Company (US)
Baxter International Inc. (US)
Gerresheimer AG (Germany)
Pfizer, Inc. (US)
Schott AG (Germany)
Sandoz (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)

【レポートの目次】

1 Study Coverage
1.1 Injectable Drug Delivery Formulation Product Introduction
1.2 Market Segments
1.3 Key Injectable Drug Delivery Formulation Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Injectable Drug Delivery Formulation Market Size Growth Rate by Type
1.4.2 Conventional Drug Delivery Formulations
1.4.3 Novel Drug Delivery Formulations
1.4.4 Long-acting Formulations
1.5 Market by Application
1.5.1 Global Injectable Drug Delivery Formulation Market Size Growth Rate by Application
1.5.2 Autoimmune Diseases
1.5.3 Hormonal Disorders
1.5.4 Oncology
1.5.5 Orphan Diseases
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Injectable Drug Delivery Formulation Market Size, Estimates and Forecasts
2.1.1 Global Injectable Drug Delivery Formulation Revenue 2015-2026
2.1.2 Global Injectable Drug Delivery Formulation Sales 2015-2026
2.2 Global Injectable Drug Delivery Formulation, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Injectable Drug Delivery Formulation Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Injectable Drug Delivery Formulation Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Injectable Drug Delivery Formulation Competitor Landscape by Players
3.1 Injectable Drug Delivery Formulation Sales by Manufacturers
3.1.1 Injectable Drug Delivery Formulation Sales by Manufacturers (2015-2020)
3.1.2 Injectable Drug Delivery Formulation Sales Market Share by Manufacturers (2015-2020)
3.2 Injectable Drug Delivery Formulation Revenue by Manufacturers
3.2.1 Injectable Drug Delivery Formulation Revenue by Manufacturers (2015-2020)
3.2.2 Injectable Drug Delivery Formulation Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Injectable Drug Delivery Formulation Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Injectable Drug Delivery Formulation Revenue in 2019
3.2.5 Global Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Injectable Drug Delivery Formulation Price by Manufacturers
3.4 Injectable Drug Delivery Formulation Manufacturing Base Distribution, Product Types
3.4.1 Injectable Drug Delivery Formulation Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Injectable Drug Delivery Formulation Product Type
3.4.3 Date of International Manufacturers Enter into Injectable Drug Delivery Formulation Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Injectable Drug Delivery Formulation Market Size by Type (2015-2020)
4.1.1 Global Injectable Drug Delivery Formulation Sales by Type (2015-2020)
4.1.2 Global Injectable Drug Delivery Formulation Revenue by Type (2015-2020)
4.1.3 Injectable Drug Delivery Formulation Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Injectable Drug Delivery Formulation Market Size Forecast by Type (2021-2026)
4.2.1 Global Injectable Drug Delivery Formulation Sales Forecast by Type (2021-2026)
4.2.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Type (2021-2026)
4.2.3 Injectable Drug Delivery Formulation Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Injectable Drug Delivery Formulation Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Injectable Drug Delivery Formulation Market Size by Application (2015-2020)
5.1.1 Global Injectable Drug Delivery Formulation Sales by Application (2015-2020)
5.1.2 Global Injectable Drug Delivery Formulation Revenue by Application (2015-2020)
5.1.3 Injectable Drug Delivery Formulation Price by Application (2015-2020)
5.2 Injectable Drug Delivery Formulation Market Size Forecast by Application (2021-2026)
5.2.1 Global Injectable Drug Delivery Formulation Sales Forecast by Application (2021-2026)
5.2.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Application (2021-2026)
5.2.3 Global Injectable Drug Delivery Formulation Price Forecast by Application (2021-2026)

6 North America
6.1 North America Injectable Drug Delivery Formulation by Country
6.1.1 North America Injectable Drug Delivery Formulation Sales by Country
6.1.2 North America Injectable Drug Delivery Formulation Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Injectable Drug Delivery Formulation Market Facts & Figures by Type
6.3 North America Injectable Drug Delivery Formulation Market Facts & Figures by Application

7 Europe
7.1 Europe Injectable Drug Delivery Formulation by Country
7.1.1 Europe Injectable Drug Delivery Formulation Sales by Country
7.1.2 Europe Injectable Drug Delivery Formulation Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Injectable Drug Delivery Formulation Market Facts & Figures by Type
7.3 Europe Injectable Drug Delivery Formulation Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Injectable Drug Delivery Formulation by Region
8.1.1 Asia Pacific Injectable Drug Delivery Formulation Sales by Region
8.1.2 Asia Pacific Injectable Drug Delivery Formulation Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Injectable Drug Delivery Formulation Market Facts & Figures by Type
8.3 Asia Pacific Injectable Drug Delivery Formulation Market Facts & Figures by Application

9 Latin America
9.1 Latin America Injectable Drug Delivery Formulation by Country
9.1.1 Latin America Injectable Drug Delivery Formulation Sales by Country
9.1.2 Latin America Injectable Drug Delivery Formulation Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Injectable Drug Delivery Formulation Market Facts & Figures by Type
9.3 Central & South America Injectable Drug Delivery Formulation Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Injectable Drug Delivery Formulation by Country
10.1.1 Middle East and Africa Injectable Drug Delivery Formulation Sales by Country
10.1.2 Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Injectable Drug Delivery Formulation Market Facts & Figures by Type
10.3 Middle East and Africa Injectable Drug Delivery Formulation Market Facts & Figures by Application

11 Company Profiles
11.1 Becton, Dickinson and Company (US)
11.1.1 Becton, Dickinson and Company (US) Corporation Information
11.1.2 Becton, Dickinson and Company (US) Description and Business Overview
11.1.3 Becton, Dickinson and Company (US) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Products Offered
11.1.5 Becton, Dickinson and Company (US) Related Developments
11.2 Baxter International Inc. (US)
11.2.1 Baxter International Inc. (US) Corporation Information
11.2.2 Baxter International Inc. (US) Description and Business Overview
11.2.3 Baxter International Inc. (US) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Products Offered
11.2.5 Baxter International Inc. (US) Related Developments
11.3 Gerresheimer AG (Germany)
11.3.1 Gerresheimer AG (Germany) Corporation Information
11.3.2 Gerresheimer AG (Germany) Description and Business Overview
11.3.3 Gerresheimer AG (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Products Offered
11.3.5 Gerresheimer AG (Germany) Related Developments
11.4 Pfizer, Inc. (US)
11.4.1 Pfizer, Inc. (US) Corporation Information
11.4.2 Pfizer, Inc. (US) Description and Business Overview
11.4.3 Pfizer, Inc. (US) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Products Offered
11.4.5 Pfizer, Inc. (US) Related Developments
11.5 Schott AG (Germany)
11.5.1 Schott AG (Germany) Corporation Information
11.5.2 Schott AG (Germany) Description and Business Overview
11.5.3 Schott AG (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Schott AG (Germany) Injectable Drug Delivery Formulation Products Offered
11.5.5 Schott AG (Germany) Related Developments
11.6 Sandoz (Germany)
11.6.1 Sandoz (Germany) Corporation Information
11.6.2 Sandoz (Germany) Description and Business Overview
11.6.3 Sandoz (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sandoz (Germany) Injectable Drug Delivery Formulation Products Offered
11.6.5 Sandoz (Germany) Related Developments
11.7 Teva Pharmaceutical Industries Ltd. (Israel)
11.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
11.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Description and Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Products Offered
11.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Related Developments
11.8 Eli Lilly and Company (US)
11.8.1 Eli Lilly and Company (US) Corporation Information
11.8.2 Eli Lilly and Company (US) Description and Business Overview
11.8.3 Eli Lilly and Company (US) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Products Offered
11.8.5 Eli Lilly and Company (US) Related Developments
11.1 Becton, Dickinson and Company (US)
11.1.1 Becton, Dickinson and Company (US) Corporation Information
11.1.2 Becton, Dickinson and Company (US) Description and Business Overview
11.1.3 Becton, Dickinson and Company (US) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Products Offered
11.1.5 Becton, Dickinson and Company (US) Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Injectable Drug Delivery Formulation Market Estimates and Projections by Region
12.1.1 Global Injectable Drug Delivery Formulation Sales Forecast by Regions 2021-2026
12.1.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Regions 2021-2026
12.2 North America Injectable Drug Delivery Formulation Market Size Forecast (2021-2026)
12.2.1 North America: Injectable Drug Delivery Formulation Sales Forecast (2021-2026)
12.2.2 North America: Injectable Drug Delivery Formulation Revenue Forecast (2021-2026)
12.2.3 North America: Injectable Drug Delivery Formulation Market Size Forecast by Country (2021-2026)
12.3 Europe Injectable Drug Delivery Formulation Market Size Forecast (2021-2026)
12.3.1 Europe: Injectable Drug Delivery Formulation Sales Forecast (2021-2026)
12.3.2 Europe: Injectable Drug Delivery Formulation Revenue Forecast (2021-2026)
12.3.3 Europe: Injectable Drug Delivery Formulation Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Injectable Drug Delivery Formulation Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Injectable Drug Delivery Formulation Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Injectable Drug Delivery Formulation Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Injectable Drug Delivery Formulation Market Size Forecast by Region (2021-2026)
12.5 Latin America Injectable Drug Delivery Formulation Market Size Forecast (2021-2026)
12.5.1 Latin America: Injectable Drug Delivery Formulation Sales Forecast (2021-2026)
12.5.2 Latin America: Injectable Drug Delivery Formulation Revenue Forecast (2021-2026)
12.5.3 Latin America: Injectable Drug Delivery Formulation Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Injectable Drug Delivery Formulation Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Injectable Drug Delivery Formulation Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Injectable Drug Delivery Formulation Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Injectable Drug Delivery Formulation Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Injectable Drug Delivery Formulation Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Injectable Drug Delivery Formulation Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Injectable Drug Delivery Formulation Market Segments
Table 2. Ranking of Global Top Injectable Drug Delivery Formulation Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Injectable Drug Delivery Formulation Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Conventional Drug Delivery Formulations
Table 5. Major Manufacturers of Novel Drug Delivery Formulations
Table 6. Major Manufacturers of Long-acting Formulations
Table 7. Global Injectable Drug Delivery Formulation Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global Injectable Drug Delivery Formulation Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global Injectable Drug Delivery Formulation Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Injectable Drug Delivery Formulation Sales Market Share by Regions (2015-2020)
Table 11. Global Injectable Drug Delivery Formulation Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Injectable Drug Delivery Formulation Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global Injectable Drug Delivery Formulation Sales Share by Manufacturers (2015-2020)
Table 14. Global Injectable Drug Delivery Formulation Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Injectable Drug Delivery Formulation by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Drug Delivery Formulation as of 2019)
Table 16. Injectable Drug Delivery Formulation Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Injectable Drug Delivery Formulation Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Injectable Drug Delivery Formulation Price (2015-2020) (USD/Pcs)
Table 19. Injectable Drug Delivery Formulation Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Injectable Drug Delivery Formulation Product Type
Table 21. Date of International Manufacturers Enter into Injectable Drug Delivery Formulation Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 24. Global Injectable Drug Delivery Formulation Sales Share by Type (2015-2020)
Table 25. Global Injectable Drug Delivery Formulation Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Injectable Drug Delivery Formulation Revenue Share by Type (2015-2020)
Table 27. Injectable Drug Delivery Formulation Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 29. Global Injectable Drug Delivery Formulation Sales Share by Application (2015-2020)
Table 30. North America Injectable Drug Delivery Formulation Sales by Country (2015-2020) (K Pcs)
Table 31. North America Injectable Drug Delivery Formulation Sales Market Share by Country (2015-2020)
Table 32. North America Injectable Drug Delivery Formulation Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Injectable Drug Delivery Formulation Revenue Market Share by Country (2015-2020)
Table 34. North America Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 35. North America Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Table 36. North America Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 37. North America Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Table 38. Europe Injectable Drug Delivery Formulation Sales by Country (2015-2020) (K Pcs)
Table 39. Europe Injectable Drug Delivery Formulation Sales Market Share by Country (2015-2020)
Table 40. Europe Injectable Drug Delivery Formulation Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country (2015-2020)
Table 42. Europe Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 43. Europe Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Table 44. Europe Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 45. Europe Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Injectable Drug Delivery Formulation Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Injectable Drug Delivery Formulation Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Injectable Drug Delivery Formulation Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Table 54. Latin America Injectable Drug Delivery Formulation Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America Injectable Drug Delivery Formulation Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Injectable Drug Delivery Formulation Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Injectable Drug Delivery Formulation Revenue Market Share by Country (2015-2020)
Table 58. Latin America Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Table 60. Latin America Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Injectable Drug Delivery Formulation Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Table 70. Becton, Dickinson and Company (US) Corporation Information
Table 71. Becton, Dickinson and Company (US) Description and Major Businesses
Table 72. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Becton, Dickinson and Company (US) Product
Table 74. Becton, Dickinson and Company (US) Recent Development
Table 75. Baxter International Inc. (US) Corporation Information
Table 76. Baxter International Inc. (US) Description and Major Businesses
Table 77. Baxter International Inc. (US) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Baxter International Inc. (US) Product
Table 79. Baxter International Inc. (US) Recent Development
Table 80. Gerresheimer AG (Germany) Corporation Information
Table 81. Gerresheimer AG (Germany) Description and Major Businesses
Table 82. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Gerresheimer AG (Germany) Product
Table 84. Gerresheimer AG (Germany) Recent Development
Table 85. Pfizer, Inc. (US) Corporation Information
Table 86. Pfizer, Inc. (US) Description and Major Businesses
Table 87. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Pfizer, Inc. (US) Product
Table 89. Pfizer, Inc. (US) Recent Development
Table 90. Schott AG (Germany) Corporation Information
Table 91. Schott AG (Germany) Description and Major Businesses
Table 92. Schott AG (Germany) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Schott AG (Germany) Product
Table 94. Schott AG (Germany) Recent Development
Table 95. Sandoz (Germany) Corporation Information
Table 96. Sandoz (Germany) Description and Major Businesses
Table 97. Sandoz (Germany) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Sandoz (Germany) Product
Table 99. Sandoz (Germany) Recent Development
Table 100. Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
Table 101. Teva Pharmaceutical Industries Ltd. (Israel) Description and Major Businesses
Table 102. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Teva Pharmaceutical Industries Ltd. (Israel) Product
Table 104. Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
Table 105. Eli Lilly and Company (US) Corporation Information
Table 106. Eli Lilly and Company (US) Description and Major Businesses
Table 107. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Eli Lilly and Company (US) Product
Table 109. Eli Lilly and Company (US) Recent Development
Table 110. Global Injectable Drug Delivery Formulation Sales Forecast by Regions (2021-2026) (K Pcs)
Table 111. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Regions (2021-2026)
Table 112. Global Injectable Drug Delivery Formulation Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 113. Global Injectable Drug Delivery Formulation Revenue Market Share Forecast by Regions (2021-2026)
Table 114. North America: Injectable Drug Delivery Formulation Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. North America: Injectable Drug Delivery Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Europe: Injectable Drug Delivery Formulation Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. Europe: Injectable Drug Delivery Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Asia Pacific: Injectable Drug Delivery Formulation Sales Forecast by Region (2021-2026) (K Pcs)
Table 119. Asia Pacific: Injectable Drug Delivery Formulation Revenue Forecast by Region (2021-2026) (US$ Million)
Table 120. Latin America: Injectable Drug Delivery Formulation Sales Forecast by Country (2021-2026) (K Pcs)
Table 121. Latin America: Injectable Drug Delivery Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Middle East and Africa: Injectable Drug Delivery Formulation Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Middle East and Africa: Injectable Drug Delivery Formulation Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Injectable Drug Delivery Formulation Players
Table 128. Injectable Drug Delivery Formulation Customers List
Table 129. Injectable Drug Delivery Formulation Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable Drug Delivery Formulation Product Picture
Figure 2. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2020 & 2026
Figure 3. Conventional Drug Delivery Formulations Product Picture
Figure 4. Novel Drug Delivery Formulations Product Picture
Figure 5. Long-acting Formulations Product Picture
Figure 6. Global Injectable Drug Delivery Formulation Sales Market Share by Application in 2020 & 2026
Figure 7. Autoimmune Diseases
Figure 8. Hormonal Disorders
Figure 9. Oncology
Figure 10. Orphan Diseases
Figure 11. Others
Figure 12. Injectable Drug Delivery Formulation Report Years Considered
Figure 13. Global Injectable Drug Delivery Formulation Market Size 2015-2026 (US$ Million)
Figure 14. Global Injectable Drug Delivery Formulation Sales 2015-2026 (K Pcs)
Figure 15. Global Injectable Drug Delivery Formulation Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2015-2020)
Figure 17. Global Injectable Drug Delivery Formulation Sales Market Share by Region in 2019
Figure 18. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2015-2020)
Figure 19. Global Injectable Drug Delivery Formulation Revenue Market Share by Region in 2019
Figure 20. Global Injectable Drug Delivery Formulation Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Injectable Drug Delivery Formulation Revenue in 2019
Figure 22. Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2015-2020)
Figure 24. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2019
Figure 25. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2015-2020)
Figure 26. Global Injectable Drug Delivery Formulation Revenue Market Share by Type in 2019
Figure 27. Global Injectable Drug Delivery Formulation Market Share by Price Range (2015-2020)
Figure 28. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
Figure 29. Global Injectable Drug Delivery Formulation Sales Market Share by Application in 2019
Figure 30. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2015-2020)
Figure 31. Global Injectable Drug Delivery Formulation Revenue Market Share by Application in 2019
Figure 32. North America Injectable Drug Delivery Formulation Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Injectable Drug Delivery Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Injectable Drug Delivery Formulation Sales Market Share by Country in 2019
Figure 35. North America Injectable Drug Delivery Formulation Revenue Market Share by Country in 2019
Figure 36. U.S. Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Injectable Drug Delivery Formulation Market Share by Type in 2019
Figure 41. North America Injectable Drug Delivery Formulation Market Share by Application in 2019
Figure 42. Europe Injectable Drug Delivery Formulation Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Injectable Drug Delivery Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Injectable Drug Delivery Formulation Sales Market Share by Country in 2019
Figure 45. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country in 2019
Figure 46. Germany Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Injectable Drug Delivery Formulation Market Share by Type in 2019
Figure 57. Europe Injectable Drug Delivery Formulation Market Share by Application in 2019
Figure 58. Asia Pacific Injectable Drug Delivery Formulation Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Injectable Drug Delivery Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Region in 2019
Figure 61. Asia Pacific Injectable Drug Delivery Formulation Revenue Market Share by Region in 2019
Figure 62. China Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Injectable Drug Delivery Formulation Market Share by Type in 2019
Figure 85. Asia Pacific Injectable Drug Delivery Formulation Market Share by Application in 2019
Figure 86. Latin America Injectable Drug Delivery Formulation Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Injectable Drug Delivery Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Injectable Drug Delivery Formulation Sales Market Share by Country in 2019
Figure 89. Latin America Injectable Drug Delivery Formulation Revenue Market Share by Country in 2019
Figure 90. Mexico Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Injectable Drug Delivery Formulation Market Share by Type in 2019
Figure 97. Latin America Injectable Drug Delivery Formulation Market Share by Application in 2019
Figure 98. Middle East and Africa Injectable Drug Delivery Formulation Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Injectable Drug Delivery Formulation Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Injectable Drug Delivery Formulation Revenue Market Share by Country in 2019
Figure 102. Turkey Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Injectable Drug Delivery Formulation Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Injectable Drug Delivery Formulation Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Injectable Drug Delivery Formulation Market Share by Type in 2019
Figure 109. Middle East and Africa Injectable Drug Delivery Formulation Market Share by Application in 2019
Figure 110. North America Injectable Drug Delivery Formulation Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Injectable Drug Delivery Formulation Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Injectable Drug Delivery Formulation Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Injectable Drug Delivery Formulation Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Injectable Drug Delivery Formulation Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Injectable Drug Delivery Formulation Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Injectable Drug Delivery Formulation Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Injectable Drug Delivery Formulation Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Injectable Drug Delivery Formulation Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Injectable Drug Delivery Formulation Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed


【掲載企業】

Becton, Dickinson and Company (US)、Baxter International Inc. (US)、Gerresheimer AG (Germany)、Pfizer, Inc. (US)、Schott AG (Germany)、Sandoz (Germany)、Teva Pharmaceutical Industries Ltd. (Israel)、Eli Lilly and Company (US)

★調査レポート[世界の注射可能ドラッグデリバリー製剤市場インサイト及び予測(~2026年)] (コード:QYR20NV01692)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の注射可能ドラッグデリバリー製剤市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆